Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELUTIA INC.AZYO · Entity 7342 | CHIEF COMMERCIAL OFFICER | March 08, 2023 | March 10, 2023 |
| Tonix Pharmaceuticals Holding Corp.TNXP · Entity 6169 | Chief Commercial Officer | September 04, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELUTIA INC.
Report date March 08, 2023 · Filed March 10, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 17,917 |
Ending reported balance
After 2023-03-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-03-08 · Exercise / conversion · Acquired 937 · Balance 18,206 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs"). Row 2 · 2023-03-09 · Sale · Disposed 289 · Balance 17,917 F2: Represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,875 |
Reported balance
After 2023-03-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-08 · Exercise / conversion · Disposed 937 · Balance 1,875 F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs"). F3: On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs").
F2: Represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F3: On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022.
Tonix Pharmaceuticals Holding Corp.
Report date September 04, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 694 |
Reported balance
Holding disclosure · report date 2026-09-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 694 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $16.51 · Expires 2034-09-09 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-09-04 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: The option was granted on September 9, 2024, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $8.05 · Expires 2035-02-25 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-09-04 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F2: The option was granted on February 25, 2025, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $20.18 · Expires 2035-05-13 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-09-04 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F3: The option was granted on May 13, 2025, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/4th on the first anniversary of issuance and 1/48th each month thereafter for 36 months. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $14.29 · Expires 2036-02-24 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-09-04 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F4: The option was granted on February 24, 2026, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/4th on the first anniversary of issuance and 1/48th each month thereafter for 36 months. |
Filing footnotes · ownership attribution and instrument terms
F1: The option was granted on September 9, 2024, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F2: The option was granted on February 25, 2025, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
F3: The option was granted on May 13, 2025, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/4th on the first anniversary of issuance and 1/48th each month thereafter for 36 months.
F4: The option was granted on February 24, 2026, pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended. The option vests 1/4th on the first anniversary of issuance and 1/48th each month thereafter for 36 months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 09, 2023 Filed Mar 10, 2023 02:18 UTC | ELUTIA INC. AZYO · Entity 7342 | SaleClass A Common Stock | 289 | $4.30 | $1,242.70 |
DisclosureSEC source: 0001415889-23-004626 · form4-03102023_020301.xml · nonDerivative · entry 2 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,917 F2 · kind: Represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 02:18 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionRestricted Stock Units · Derivative | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004626 · form4-03102023_020301.xml · derivative · entry 3 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,875 Underlying: Class A Common Stock · 937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs"). F3 · derivative.exercise_date: On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022. F3 · derivative.expiration_date: On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 02:18 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionClass A Common Stock | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004626 · form4-03102023_020301.xml · nonDerivative · entry 1 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,206 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs"). Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 21:05 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionRestricted Stock Units · Derivative | 15,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-009538 · form4-09122022_020936.xml · derivative · entry 3 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 15,390 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units. F3 · derivative.exercise_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022. F3 · derivative.expiration_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 21:05 UTC | ELUTIA INC. AZYO · Entity 7342 | Tax withholdingClass A Common Stock | 4,728 | $7.30 | $34,514.40 |
DisclosureSEC source: 0001415889-22-009538 · form4-09122022_020936.xml · nonDerivative · entry 2 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,269 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units. Read SEC document |
| September 08, 2022 Filed Sep 12, 2022 21:05 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionClass A Common Stock | 15,390 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-009538 · form4-09122022_020936.xml · nonDerivative · entry 1 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,997 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 01:46 UTC | ELUTIA INC. AZYO · Entity 7342 | SaleClass A Common Stock | 276 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-22-002868 · form4-03102022_050356.xml · nonDerivative · entry 2 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,607 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.16 to $5.34. The Reporting Person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:46 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantRestricted Stock Units · Derivative | 15,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002868 · form4-03102022_050356.xml · derivative · entry 6 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,390 Underlying: Class A Common Stock · 15,390 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock. F8 · derivative.exercise_date: The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date. F8 · derivative.expiration_date: The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:46 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionRestricted Stock Units · Derivative | 938 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002868 · form4-03102022_050356.xml · derivative · entry 5 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,812 Underlying: Class A Common Stock · 938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis. F7 · derivative.exercise_date: On March 8, 2021, the Reporting Person was granted 3,750 restricted stock units, vesting in four substantially equal annual installments beginning in March 8, 2022. F7 · derivative.expiration_date: On March 8, 2021, the Reporting Person was granted 3,750 restricted stock units, vesting in four substantially equal annual installments beginning in March 8, 2022. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:46 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantRestricted Stock Units · Derivative | 8,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002868 · form4-03102022_050356.xml · derivative · entry 4 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,700 Underlying: Class A Common Stock · 8,700 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock. F6 · derivative.exercise_date: The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024. F6 · derivative.expiration_date: The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:46 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $5.08 | $0.00 |
DisclosureSEC source: 0001415889-22-002868 · form4-03102022_050356.xml · derivative · entry 3 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,000 Underlying: Class A Common Stock · 31,000 shares Expires 2032-03-08 F4 · derivative.exercise_date: The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:46 UTC | ELUTIA INC. AZYO · Entity 7342 | Exercise / conversionClass A Common Stock | 938 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-002868 · form4-03102022_050356.xml · nonDerivative · entry 1 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,883 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis. F2 · balance_after: Includes 857 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan. Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 21:45 UTC | ELUTIA INC. AZYO · Entity 7342 | PurchaseClass A Common Stock | 4,580 | $6.10 | $27,938.00 |
DisclosureSEC source: 0001415889-21-005960 · form4-12152021_011220.xml · nonDerivative · entry 1 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,088 F1 · balance_after: Includes 508 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:21 UTC | ELUTIA INC. AYZO · Entity 7342 | GrantRESTRICTED STOCK UNITS · Derivative | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-034473 · tm219212-6_4seq1.xml · derivative · entry 2 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: CLASS A COMMON STOCK · 3,750 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F3 · derivative.exercise_date: The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date. F3 · derivative.expiration_date: The restricted stock units vest in 4 substantially equal annual installments beginning on March 8, 2022 and have no expiration date. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 21:21 UTC | ELUTIA INC. AYZO · Entity 7342 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 22,500 | $0.00 Strike: $14.53 | $0.00 |
DisclosureSEC source: 0001104659-21-034473 · tm219212-6_4seq1.xml · derivative · entry 1 Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: CLASS A COMMON STOCK · 22,500 shares Expires 2031-03-08 F1 · derivative.exercise_date: This option vests as to 25% of the shares on March 8, 2022, and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2025. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 00:27 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantRestricted Stock Units · Derivative | 13,890 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113577 · a4.xml · derivative · entry 2 Englese Thomas · CIK 0001825799 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,890 Underlying: Class A Common Stock · 13,890 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F3 · derivative.exercise_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. F3 · derivative.expiration_date: The restricted stock units will vest in full on October 7, 2023 and do not have an expiration date. Read SEC document |
| October 07, 2020 Filed Oct 9, 2020 00:27 UTC | ELUTIA INC. AZYO · Entity 7342 | GrantStock Option (Right to Buy) · Derivative | 33,488 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-20-113577 · a4.xml · derivative · entry 1 Englese Thomas · CIK 0001825799 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,488 Underlying: Class A Common Stock · 33,488 shares Expires 2030-10-06 F1 · derivative.exercise_date: This option vests and becomes exercisable in 4 substantially equal annual installments on each of the successive years following October 7, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.